{"protocolSection":{"identificationModule":{"nctId":"NCT04253275","orgStudyIdInfo":{"id":"IBIS-CT (29BRC19.0268)"},"organization":{"fullName":"University Hospital, Brest","class":"OTHER"},"briefTitle":"Identification of Biomarkers in Ischemic Stroke - Clinical Trial","officialTitle":"Identification of Biomarkers in Ischemic Stroke - Clinical Trial","acronym":"IBIS-CT"},"statusModule":{"statusVerifiedDate":"2023-05","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2020-11-24","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2024-08","type":"ESTIMATED"},"completionDateStruct":{"date":"2024-08","type":"ESTIMATED"},"studyFirstSubmitDate":"2020-01-07","studyFirstSubmitQcDate":"2020-01-31","studyFirstPostDateStruct":{"date":"2020-02-05","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-05-10","lastUpdatePostDateStruct":{"date":"2023-05-12","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"University Hospital, Brest","class":"OTHER"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The objective of the study is to determine RNA blood biomarker based on 9 genes already identified in experimental studies, whose expression would be significantly increased in patient with ischemic stroke compared to controls.","detailedDescription":"This is a monocentric study. It's a case-control study with case being first-ever ischemic stroke and controls being healthy (stroke free) subject patients paired for age, sex and cardiovascular risk or hemorrhagic stroke paired for age and sex.\n\nPatients are followed for one year. Blood samples will be taken at inclusion, 12h, 24h, 48h, 7d, 3m and 1y. Microvesicles samples will be taken at inclusion, 7d and 3M."},"conditionsModule":{"conditions":["Stroke, Ischemic","Stroke Hemorrhagic"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"NON_RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"OTHER","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":60,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Ischemic stroke patients","type":"OTHER","description":"Patients with ischemic stroke diagnosed on clinical presentation and cerebral imaging","interventionNames":["Genetic: blood samples"]},{"label":"hemorragic stroke patients","type":"OTHER","description":"Patients with hemorragic stroke diagnosed on clinical presentation and cerebral imaging","interventionNames":["Genetic: blood samples"]},{"label":"healthy controls","type":"OTHER","description":"Stroke-free","interventionNames":["Genetic: blood samples","Diagnostic Test: MRI without injection"]}],"interventions":[{"type":"GENETIC","name":"blood samples","description":"Blood samples will be taken at inclusion, 12h, 24h, 48h, 7d, 3m and 1y for patients ; at inclusion, 3m and 1y for controls.\n\nMicrovesicles samples will be taken at inclusion, 7d and 3M ; at inclusion and 3M for controls.","armGroupLabels":["Ischemic stroke patients","healthy controls","hemorragic stroke patients"]},{"type":"DIAGNOSTIC_TEST","name":"MRI without injection","description":"MRI at inclusion for controls","armGroupLabels":["healthy controls"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Expression (measured in log2) of each 9 targeted genes identified less than 6 hours after inclusion","description":"Each targeted genes will be measured by quantitative reverse transcription Polymerase Chain Reaction (rt-PCR)","timeFrame":"6 hours after inclusion"}],"secondaryOutcomes":[{"measure":"RNA level expression across time according growth of infarction measured at inclusion and at 3 months","description":"Each targeted genes will be measured by quantitative rt-PCR","timeFrame":"inclusion and 3 months"},{"measure":"RNA level expression across time according Rankin scale at three months dichotomized in good (â‰¤ 2) and bad prognosis (> 3).","description":"Each targeted genes will be measured by quantitative rt-PCR","timeFrame":"at 3 months"},{"measure":"Targeted RNA level expression according mechanism of ischemic stroke","description":"Each targeted RNA level expression of targeted genes will be measured by quantitative rt-PCR","timeFrame":"at 3 months"},{"measure":"Target RNA level expression in the saliva","description":"For 3 participants, one of each arm, a saliva sample will be collected at inclusion.","timeFrame":"at inclusion"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* For ischemic stroke :\n* Age \\> 18-year-old\n* Ischemic stroke diagnosed on clinical presentation and cerebral imaging (CT or MRI imaging)\n* Inclusion inferior to 6 hours from stroke onset\n* Initial NIHSS score \\> 0 at the time of clinical examination\n* Patients with multimodal imaging either through MRI or CT perfusion and supra-aortic vessels and intra-cerebral vessels (Willis circle) imaging \\<0\n* Procedure of signed consent in situation of emergency : consent of the patient if he has the possibility to sign or his representative if he is present\n* For hemorragic stroke :\n* Age \\> 18 year-old\n* Hemorrhagic stroke diagnosed on clinical presentation and cerebral imaging (CT or MRI imaging)\n* Inclusion inferior to 6 hours from stroke onset\n* Initial NIHSS score \\> 0 at the time of clinical examination\n* Hemorrhagic patients are paired for age and sex with ischemic patients\n* Procedure of signed consent in situation of emergency : consent of the patient if he has the possibility to sign or his representative if he is present\n\nFor healthy controls :\n\n* Age \\> 18 year-old\n* Stroke-free standardized questionnaire\n* Initial NIHSS score = 0\n* Rankin score = 0\n* High risk cardiovascular subjects\n* Controls are paired for age, sex and cardiovascular risk measured by a score (European Heart Score) with ischemic patients\n\nExclusion Criteria:\n\n* Not affiliated to social security\n* Patient under legal protection or deprived of liberty by a judicial or administrative decision\n* Patient whose follow-up will be impossible\n* Prior stroke\n\nGROUP FOR ISCHEMIC STROKE :\n\n- Patients with TIA and a negative cerebral CT or MRI\n\nGROUP FOR HEMORRAGIC STROKE :\n\n* Cerebral hemorrhage related to subarachnoid hemorrhage\n* Post-traumatic hemorrhage\n* Hemorrhagic transformation in patients with ischemic stroke\n\nGROUP FOR HEALTHY CONTROLS :\n\n- Contraindication MRI","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"99 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Serge TIMSIT, Pr","role":"CONTACT","phone":"298147349","phoneExt":"+33","email":"serge.timsit@chu-brest.fr"}],"overallOfficials":[{"name":"Serge TIMSIT, Pr","affiliation":"serge.timsit@chu-brest.fr","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"CHRU Brest","status":"RECRUITING","city":"Brest","country":"France","contacts":[{"name":"Serge TIMSIT, PU-PH","role":"CONTACT","email":"serge.timsit@chu-brest.fr"},{"name":"Serge TIMSIT, PU-PH","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":48.3903,"lon":-4.48628}}]},"ipdSharingStatementModule":{"ipdSharing":"YES","description":"All collected data that underlie results in a publication","infoTypes":["STUDY_PROTOCOL"],"timeFrame":"Data will be available after the publication of result and ending fifteen years following the last visit of the last patient","accessCriteria":"Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement."}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000083302","term":"Hemorrhagic Stroke"},{"id":"D000007511","term":"Ischemia"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","asFound":"Ischemic","relevance":"HIGH"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M2405","name":"Hemorrhagic Stroke","asFound":"Stroke Hemorrhagic","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]}},"hasResults":false}